• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有生长分化因子2(GDF2)和骨形态发生蛋白受体2(BMPR2)变异的肺动脉高压患者的血流动力学和临床特征

Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.

作者信息

Wang Mei-Tzu, Weng Ken-Pen, Chang Sheng-Kai, Huang Wei-Chun, Chen Lee-Wei

机构信息

Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.

Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.

出版信息

Int J Mol Sci. 2024 Feb 27;25(5):2734. doi: 10.3390/ijms25052734.

DOI:10.3390/ijms25052734
PMID:38473983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10931624/
Abstract

Asians have a higher carrier rate of pulmonary arterial hypertension (PAH)-related genetic variants than Caucasians do. This study aimed to identify PAH-related genetic variants using whole exome sequencing (WES) in Asian idiopathic and heritable PAH cohorts. A WES library was constructed, and candidate variants were further validated by polymerase chain reaction and Sanger sequencing in the PAH cohort. In a total of 69 patients, the highest incidence of variants was found in the BMPR2, , and genes. Regarding the gene variants, there were two nonsense variants (c.994C>T, p. Arg332*; c.1750C>T, p. Arg584*), one missense variant (c.1478C>T, p. Thr493Ile), and one novel in-frame deletion variant (c.877_888del, p. Leu293_Ser296del). Regarding the variants, there was one likely pathogenic nonsense variant (c.259C>T, p. Gln87*) and two missense variants (c.1207G>A, p. Val403Ile; c.38T>C, p. Leu13Pro). The and variant subgroups had worse hemodynamics. Moreover, the variant patients were younger and had a significantly lower GDF2 value (135.6 ± 36.2 pg/mL, = 0.002) in comparison to the value in the non-/non- mutant group (267.8 ± 185.8 pg/mL). The variant carriers had worse hemodynamics compared to the patients with the non-/non- mutant group. Moreover, there was a significantly lower GDF2 value in the variant carriers compared to the control group. may be a protective or corrected modifier in certain genetic backgrounds.

摘要

亚洲人肺动脉高压(PAH)相关基因变异的携带率高于白种人。本研究旨在通过全外显子组测序(WES)在亚洲特发性和遗传性PAH队列中鉴定PAH相关基因变异。构建了WES文库,并在PAH队列中通过聚合酶链反应和桑格测序对候选变异进行进一步验证。在总共69例患者中,发现BMPR2等基因变异的发生率最高。关于该基因变异,有两个无义变异(c.994C>T,p.Arg332*;c.1750C>T,p.Arg584*)、一个错义变异(c.1478C>T,p.Thr493Ile)和一个新的框内缺失变异(c.877_888del,p.Leu293_Ser296del)。关于该变异,有一个可能致病的无义变异(c.259C>T,p.Gln87*)和两个错义变异(c.1207G>A,p.Val403Ile;c.38T>C,p.Leu13Pro)。该和变异亚组的血流动力学较差。此外,与非/非突变组相比,该变异患者更年轻,GDF2值显著更低(135.6±36.2 pg/mL,P = 0.002),非/非突变组的值为(267.8±185.8 pg/mL)。与非/非突变组患者相比,该变异携带者的血流动力学更差。此外,与对照组相比,该变异携带者的GDF2值显著更低。在某些遗传背景下可能是一种保护性或校正性修饰因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/0ff30f730add/ijms-25-02734-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/ba4fb823be69/ijms-25-02734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/d80286478cc7/ijms-25-02734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/209c3628cb7b/ijms-25-02734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/56d311d3d895/ijms-25-02734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/9591c179a703/ijms-25-02734-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/0ff30f730add/ijms-25-02734-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/ba4fb823be69/ijms-25-02734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/d80286478cc7/ijms-25-02734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/209c3628cb7b/ijms-25-02734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/56d311d3d895/ijms-25-02734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/9591c179a703/ijms-25-02734-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c8/10931624/0ff30f730add/ijms-25-02734-g006.jpg

相似文献

1
Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.伴有生长分化因子2(GDF2)和骨形态发生蛋白受体2(BMPR2)变异的肺动脉高压患者的血流动力学和临床特征
Int J Mol Sci. 2024 Feb 27;25(5):2734. doi: 10.3390/ijms25052734.
2
Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan.台湾中部遗传性和特发性肺动脉高压患者的全外显子组测序
Front Cardiovasc Med. 2022 Jun 22;9:911649. doi: 10.3389/fcvm.2022.911649. eCollection 2022.
3
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.遗传性肺动脉高压相关罕见序列变异的鉴定。
Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.
4
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension.基因panel 诊断揭示肺动脉高压中的新致病性变异。
Respir Res. 2022 Mar 27;23(1):74. doi: 10.1186/s12931-022-01987-x.
5
The features of rare pathogenic BMPR2 variants in pulmonary arterial hypertension: Comparison between patients and reference population.肺动脉高压中罕见致病性BMPR2变异的特征:患者与参考人群的比较。
Int J Cardiol. 2020 Nov 1;318:138-143. doi: 10.1016/j.ijcard.2020.06.068. Epub 2020 Jul 4.
6
Promoter Variants Effect Gene Expression in Pulmonary Arterial Hypertension Patients.启动子变异影响肺动脉高压患者的基因表达。
Genes (Basel). 2020 Oct 6;11(10):1168. doi: 10.3390/genes11101168.
7
Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants.中国肺动脉高压患者携带 BMPR2 或 EIF2KAK4 变异体的临床特征和生存情况。
BMC Pulm Med. 2020 May 29;20(1):150. doi: 10.1186/s12890-020-01179-7.
8
Genetic Evaluation in a Cohort of 126 Dutch Pulmonary Arterial Hypertension Patients.126 例荷兰肺动脉高压患者队列的遗传评估。
Genes (Basel). 2020 Oct 13;11(10):1191. doi: 10.3390/genes11101191.
9
Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.韩国特发性肺动脉高压患者骨形态发生蛋白受体 2 突变的患病率和临床特征:PILGRIM 探索性队列研究。
PLoS One. 2020 Sep 23;15(9):e0238698. doi: 10.1371/journal.pone.0238698. eCollection 2020.
10
Characterization of Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.肺动脉高压中 BMP9 和 BMP10 突变和水平的特征。
Am J Respir Crit Care Med. 2020 Mar 1;201(5):575-585. doi: 10.1164/rccm.201906-1141OC.

引用本文的文献

1
The prevalence of pathogenic variants in the BMPR2 gene in patients with the idiopathic pulmonary arterial hypertension in the Russian population: sequencing data and meta-analysis.俄罗斯人群特发性肺动脉高压患者中BMPR2基因致病性变异的患病率:测序数据与荟萃分析
Respir Res. 2025 Apr 14;26(1):146. doi: 10.1186/s12931-025-03214-9.
2
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.肺动脉高压:分子机制与临床研究
MedComm (2020). 2025 Mar 10;6(3):e70134. doi: 10.1002/mco2.70134. eCollection 2025 Mar.
3
Genetic screening in cohort of Egyptian patients with pulmonary arterial hypertension disease.

本文引用的文献

1
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.定义被报道可导致肺动脉高压的基因的临床有效性。
Genet Med. 2023 Nov;25(11):100925. doi: 10.1016/j.gim.2023.100925. Epub 2023 Jul 5.
2
Taiwan Biobank: A rich biomedical research database of the Taiwanese population.台湾生物银行:一个关于台湾人群的丰富生物医学研究数据库。
Cell Genom. 2022 Oct 12;2(11):100197. doi: 10.1016/j.xgen.2022.100197. eCollection 2022 Nov 9.
3
Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan.
埃及肺动脉高压疾病患者队列中的基因筛查
Ir J Med Sci. 2025 Apr;194(2):641-648. doi: 10.1007/s11845-025-03889-5. Epub 2025 Feb 11.
4
Hemodynamic and Genetic Associations with the Risk of Idiopathic Pulmonary Arterial Hypertension Development in an Ethnic Cohort of Kazakhs.哈萨克族人群队列中血流动力学和基因与特发性肺动脉高压发生风险的关联
Diagnostics (Basel). 2024 Nov 28;14(23):2687. doi: 10.3390/diagnostics14232687.
台湾中部遗传性和特发性肺动脉高压患者的全外显子组测序
Front Cardiovasc Med. 2022 Jun 22;9:911649. doi: 10.3389/fcvm.2022.911649. eCollection 2022.
4
An adult case of NOTCH3 mutation in pulmonary artery hypertension.一例成人肺动脉高压NOTCH3基因突变病例。
Pulm Circ. 2022 Mar 4;12(1):e12050. doi: 10.1002/pul2.12050. eCollection 2022 Jan.
5
Gene Mutation Annotation and Pedigree for Pulmonary Arterial Hypertension Patients in Han Chinese Patients.中国汉族肺动脉高压患者的基因突变注释和家系分析。
Glob Heart. 2021 Oct 18;16(1):70. doi: 10.5334/gh.1002. eCollection 2021.
6
Expanding the Evidence of a Semi-Dominant Inheritance in Associated with Pulmonary Arterial Hypertension.扩展与肺动脉高压相关的半显性遗传证据。
Cells. 2021 Nov 15;10(11):3178. doi: 10.3390/cells10113178.
7
Pulmonary arterial hypertension in the elderly population.老年人群中的肺动脉高压
J Chin Med Assoc. 2022 Jan 1;85(1):18-23. doi: 10.1097/JCMA.0000000000000658.
8
Reduced Notch1 Cleavage Promotes the Development of Pulmonary Hypertension.降低 Notch1 裂解促进肺动脉高压的发生。
Hypertension. 2022 Jan;79(1):79-92. doi: 10.1161/HYPERTENSIONAHA.120.16065. Epub 2021 Nov 5.
9
Biallelic variants of cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality.双等位基因变异会导致儿童期发病的肺动脉高压,其特征是极高的发病率和死亡率。
J Med Genet. 2022 Sep;59(9):906-911. doi: 10.1136/jmedgenet-2021-107831. Epub 2021 Sep 7.
10
Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation.模仿人类肺动脉高压变化的Notch2抑制可调节Notch1并促进内皮细胞增殖。
Am J Physiol Heart Circ Physiol. 2021 Sep 1;321(3):H542-H557. doi: 10.1152/ajpheart.00125.2021. Epub 2021 Jul 23.